Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/26/2012 | CN101568550B Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
12/26/2012 | CN101495639B Resistance to powdery mildew and absence of necrosis in cucumis sativus |
12/26/2012 | CN101495630B Gene involved in immortalization of human cancer cell and use thereof |
12/26/2012 | CN101415828B Disease-resistant plants |
12/26/2012 | CN101381696B Method for constructing genetic engineering bacteria and enhancing stress resistance of 1,3-propanediol producing strain |
12/26/2012 | CN101358203B Method for preparing membrane protein based on enveloped virus budding mode of insect |
12/26/2012 | CN101210051B Anti-VEGF antibodies |
12/26/2012 | CN101139392B KDR peptides and vaccines containing the same |
12/26/2012 | CN101052720B Method of detecting H5 or H7 avian influenza virus |
12/25/2012 | US8340919 Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data |
12/25/2012 | US8338678 Maize variety hybrid X08A124 |
12/25/2012 | US8338675 Maize variety hybrid X18A636 |
12/25/2012 | US8338674 Plants and seeds of corn variety CV289398 |
12/25/2012 | US8338673 Hybrid corn plant and seed PPVO1864 |
12/25/2012 | US8338672 Pepper hybrid E42.2346 |
12/25/2012 | US8338671 Soybean variety XB31E11 |
12/25/2012 | US8338669 Soybean cultivar S080101 |
12/25/2012 | US8338668 Soybean cultivar S080135 |
12/25/2012 | US8338667 Environmental stress-inducible 972 promoter isolated from rice and uses thereof |
12/25/2012 | US8338666 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
12/25/2012 | US8338665 Methods and vectors for producing transgenic plants |
12/25/2012 | US8338664 Nucleic acid molecules encoding plant proteins in the C3HC4 family and methods for the alteration of plant cellulose and lignin content |
12/25/2012 | US8338663 Isoprenoid synthases |
12/25/2012 | US8338662 Viral promoter, truncations thereof, and methods of use |
12/25/2012 | US8338661 Transgenic plants with increased stress tolerance and yield |
12/25/2012 | US8338583 Snornai-small nucleolar RNA degradation by RNA interference in trypanosomatids |
12/25/2012 | US8338575 IL-7 fusion proteins |
12/25/2012 | US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
12/25/2012 | US8338384 Method for treating ocular neovascularization |
12/25/2012 | US8338379 Monoclonal antibody and use thereof |
12/25/2012 | US8338376 Compositions comprising variant LT-B-R-IG fusion proteins |
12/25/2012 | US8338362 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity |
12/25/2012 | US8338181 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT2 polypeptides and homologs thereof |
12/25/2012 | US8338180 Using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds |
12/25/2012 | US8338179 Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
12/25/2012 | US8338178 Mitochondrial enhancement of cells |
12/25/2012 | US8338173 Preparation of antigen-presenting human γδ T cells and use in immunotherapy |
12/25/2012 | US8338171 Baboon homolog of human CD147 |
12/25/2012 | US8338168 Chimeric glycoproteins and pseudotyped lentiviral vectors |
12/25/2012 | US8338162 Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium |
12/25/2012 | US8338158 Cis-aconitate decarboxylase mutants having improved enzymatic activity |
12/25/2012 | US8338156 Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
12/25/2012 | US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
12/25/2012 | US8338144 Microbial production of L-ascorbic acid |
12/25/2012 | US8338138 Methods for making and using molecular switches involving circular permutation |
12/25/2012 | US8338134 Expression of polypeptides from the nuclear genome of Ostreococcus sp |
12/25/2012 | US8338132 Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof |
12/25/2012 | US8338131 Amylases and methods for use in starch processing |
12/25/2012 | US8338124 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
12/25/2012 | US8338091 Methods and compositions for seamless cloning of nucleic acid molecules |
12/25/2012 | US8337868 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
12/25/2012 | US8337860 Development of dengue virus vaccine components |
12/25/2012 | US8337859 Vectors for multiple gene expression |
12/25/2012 | US8337856 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
12/25/2012 | US8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same |
12/25/2012 | US8337853 Monoclonal antibodies that bind or neutralize dengue virus |
12/25/2012 | US8337848 Monoclonal antibody for APP |
12/25/2012 | US8337841 Methods of screening for antibody light chains |
12/25/2012 | US8337831 Live, oral vaccine for protection against Shigella dysenteriae serotype 1 |
12/25/2012 | US8337830 Yeast-based vaccines as immunotherapy |
12/25/2012 | US8337817 Preparation for transnasal application |
12/20/2012 | WO2012174484A2 Identifying markers of caloric restriction and caloric restriction mimetics |
12/20/2012 | WO2012174467A2 Cord blood-derived neurons by expression of sox2 |
12/20/2012 | WO2012174337A1 Methods for preparative in vitro cloning |
12/20/2012 | WO2012174271A2 Synthetic gene clusters |
12/20/2012 | WO2012174214A1 High resolution analysis of mammalian transcriptome using gene pool specific primers |
12/20/2012 | WO2012174192A2 Method of amplifying a nucleic acid |
12/20/2012 | WO2012174187A2 Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
12/20/2012 | WO2012174139A2 Compositions and methods for making and b ioc ont aining auxotrophic transgenic plants |
12/20/2012 | WO2012174126A1 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY |
12/20/2012 | WO2012173994A2 Phase changing formulations of nucleic acid payloads |
12/20/2012 | WO2012173905A1 Salt-tolerant dna polymerases |
12/20/2012 | WO2012173390A2 Method for enhancing the production yield of human papillomavirus l1 protein |
12/20/2012 | WO2012173344A2 Expression vector for animal cells including csp-b 5'-sar factor and method for producing recombinant proteins using same |
12/20/2012 | WO2012173274A1 Nucleic acid probe for assaying nucleic acids |
12/20/2012 | WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes |
12/20/2012 | WO2012173015A1 Probe set and use thereof |
12/20/2012 | WO2012172887A1 Therapeutic agent for heart diseases and cell sheet for treating heart diseases |
12/20/2012 | WO2012172822A1 Recombinant microorganism, and method for producing alanine using said recombinant microorganism |
12/20/2012 | WO2012172556A2 Plants tolerant to abiotic stress |
12/20/2012 | WO2012172498A1 Method for producing transgenic plants having increased resistance to pathogens |
12/20/2012 | WO2012172277A1 Simian adenovirus and hybrid adenoviral vectors |
12/20/2012 | WO2012172058A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins |
12/20/2012 | WO2012172055A1 Dimeric binding proteins based on modified ubiquitins |
12/20/2012 | WO2012172054A1 Modified multimeric ubiquitin proteins binding vegf-a |
12/20/2012 | WO2012172050A1 New means and methods for producing propanediol |
12/20/2012 | WO2012172012A1 New treatment for muscular dystrophies |
12/20/2012 | WO2012171651A1 Actuator apparatus with control device |
12/20/2012 | WO2012171541A1 Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins |
12/20/2012 | WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell |
12/20/2012 | WO2012171329A1 Method for separating nucleic acid and use thereof |
12/20/2012 | WO2012171328A1 Electrophoresis device and use thereof |
12/20/2012 | WO2012171127A1 Automated size selection of nucleic acids |
12/20/2012 | WO2012171104A1 Rabies virus like particle production in plants |
12/20/2012 | WO2012171070A1 Methods of producing carbamoyl phosphate and urea |
12/20/2012 | WO2012149009A3 Polynucleotides encoding enzymes from the jute lignin biosynthetic pathway |
12/20/2012 | WO2012145601A3 Adeno-associated virus virions with variant capsid and methods of use thereof |
12/20/2012 | WO2012143375A3 Hypoallergens |
12/20/2012 | WO2012135340A3 Compositions and methods for diagnosing cancer |
12/20/2012 | WO2012131495A3 Mutant bacillus thuringiensis cry genes and methods of use |